Secrest Blakey & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$410K Buy
7,021
+1
+0% +$62 0.94% 33
2020
Q2
$456K Sell
7,020
-3
-0% -$189 1.1% 33
2020
Q1
$417K Sell
7,023
-7
-0.1% -$467 1.14% 35
2019
Q4
$522K Buy
7,030
+1,146
+19% +$80.5K 1.15% 33
2019
Q3
$371K Buy
5,884
+1
+0% +$59 0.31% 75
2019
Q2
$321K Buy
+5,883
New +$317K 0.28% 77

Other funds holding CVS

Secrest Blakey & Associates's CVS Position: Q3 2020 in Review

Secrest Blakey & Associates increased its CVS Health (CVS) stake by 0.01% in Q3 2020, buying an estimated $62 and bringing the position to 7,021 shares worth $410K. The position accounts for 0.94% of the portfolio, ranked #33.

Secrest Blakey & Associates first reported a position in CVS in Q2 2019 and has held it in 6 quarters since. The position peaked at $522K in Q4 2019. 1,816 funds tracked by Wall St. Rank hold CVS as of Q3 2020.

  • Secrest Blakey & Associates held 7,021 shares of CVS Health worth $410K as of Q3 2020.
  • Secrest Blakey & Associates bought 1 CVS Health share in Q3 2020, an estimated $62.
  • CVS Health made up 0.94% of Secrest Blakey & Associates's portfolio in Q3 2020, its #33 holding.
  • Secrest Blakey & Associates first reported a position in CVS Health in Q2 2019 and has held it in 6 quarters since.
  • Secrest Blakey & Associates's CVS Health position peaked at $522K in Q4 2019.
  • 1,816 funds tracked by Wall St. Rank held CVS Health as of Q3 2020.

Based on Secrest Blakey & Associates's 13F filing for Q3 2020, filed 13 Nov 2020.